Up-regulation of YPEL1 and YPEL5 and down-regulation of ITGA2 in erlotinib-treated EGFR-mutant non-small cell lung cancer: A bioinformatic analysis
Keywords: EGFR; epidermal growth factor receptor; NSCLC; non-small cell lung cancer; TKIs; tyrosine kinase inhibitors; GEO; Gene Expression Omnibus; PPI; protein-protein interaction; DEGs; differentially expressed genes; AXL; AXL Receptor Tyrosine Kinase; ZEB1; zin